Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Siemens Healthineers Liver Fibrosis Test Gets FDA Breakthrough Device Designation

Siemens Healthineers Liver Fibrosis Test Gets FDA Breakthrough Device Designation

Nov 08, 2018
|
staff reporter

NEW YORK (360Dx) – Siemens Healthineers said today that the US Food and Drug Administration has granted Breakthrough Device designation for its Advia Centaur Enhanced Liver Fibrosis (ELF) test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Grants EUAs for SARS-CoV-2 Tests From Clinical Enterprise, Qorvo Biotechnologies

  2. Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

  3. Snibe Diagnostic Obtains CE Mark for HIV Chemiluminescence Immunoassay

  4. Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

  5. Australian Firm AnteoTech Obtains CE Marking for COVID-19 Antigen Test, Reader

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.